Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195466 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195582 |
| ACT PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-10-26 | 2024-01-11 | 208260 |
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2024-11-08 | 2025-10-02 | 242361 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Resolved | 2019-10-24 | 2020-05-14 | 97147 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Resolved | 2021-11-18 | 2025-04-29 | 149602 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-05 | 2020-09-18 | 93166 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-19 | 2020-07-10 | 94384 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-10-10 | 2020-03-05 | 96079 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-04-10 | 2020-10-22 | 111838 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2020-08-06 | 2021-01-07 | 121852 |
| ACT QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-27 | 2020-09-17 | 123078 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-09-24 | 2020-10-01 | 124918 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2021-03-04 | 2021-04-21 | 135129 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2022-07-25 | 2023-01-19 | 165453 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-01-12 | 2023-01-19 | 180881 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-06-26 | 2023-07-12 | 196367 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2023-07-18 | 2023-10-05 | 199106 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2023-07-20 | 2023-10-06 | 199390 |
| ACT QUETIAPINE | 200MG | TABLET | Resolved | 2024-01-11 | 2024-04-11 | 215725 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREGABALIN | 75MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120033 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258622 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258627 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258631 |
| TEVA-PREGABALIN | 300MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258756 |
| TEVA-PROCTOSONE | 1% 1% 0.5% 0.5% | OINTMENT | Discontinued | 2025-04-25 | 2025-04-25 | 255840 |
| TEVA-PROFEN | 600MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258499 |
| TEVA-PROGESTERONE | 100MG | CAPSULE | Reversed | 2025-05-28 | 2025-06-20 | 258574 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
| TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
| TEVA-QUETIAPINE | 200MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65039 |
| TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65044 |
| TEVA-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65047 |
| TEVA-QUININE | 300MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104294 |
| TEVA-QUININE | 200MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125976 |
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120015 |
| TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-07-10 | 2020-07-10 | 120018 |
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 |